McFarlane Neil F.

CIK 00016810984 companiesCELEBRATION, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001681098

Recent Transactions

41 trades

Exercise/Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2025-10-10+50,000→ 241,516 total
Exercise/Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Restricted Stock Unit
2025-10-10−50,000→ 100,000 total
Sale
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2025-10-10$10.82/sh−19,500→ 222,016 total
Sale
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2025-02-14$8.05/sh−30,544→ 191,516 total
Sale
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2025-02-13$7.86/sh−61,273→ 222,060 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Restricted Stock Unit
2025-02-07+112,500→ 112,500 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2025-02-07+225,000→ 225,000 total
Exercise/Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Restricted Stock Unit
2025-01-31−233,333→ 466,667 total
Exercise/Conversion
ZEVRA THERAPEUTICS, INC.$ZVRA
Common Stock
2025-01-31+233,333→ 283,333 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2024-05-16+7,693→ 49,365 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Restricted Stock Unit
2024-01-31+700,000→ 700,000 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Restricted Stock Unit
2023-10-10+200,000→ 200,000 total
Award
ZEVRA THERAPEUTICS, INC.$ZVRA
Stock Option (right to buy)
2023-10-10+600,000→ 600,000 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2023-05-18+9,792→ 41,672 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-05-19+14,035→ 31,880 total
Award
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2022-04-06+17,845→ 17,845 total
Disposition to Issuer
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-11-24−250,000→ 0 total
Disposition from Tender
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24−600,000→ 0 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2021-11-24+75,000→ 600,000 total
Disposition to Issuer
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2021-11-24−200,000→ 0 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2021-03-02+300,000→ 525,000 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2020-03-18+100,000→ 225,000 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2020-03-18+200,000→ 200,000 total
Award
Adamas Pharmaceuticals Inc
Stock Option (Right to Buy)
2019-09-16+250,000→ 250,000 total
Award
Adamas Pharmaceuticals Inc
Common Stock
2019-09-16+125,000→ 125,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2019-05-16$18.71/sh−984→ 26,988 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2019-05-15$17.78/sh−984→ 27,972 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2018-12-20$22.00/sh−4,721→ 35,360 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2018-12-20$22.56/sh−6,404→ 28,956 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2018-12-18+11,125→ 40,081 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2018-11-14$24.64/sh−1,000→ 28,476 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2018-11-14$23.63/sh−9,000→ 29,476 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2018-11-09+10,000→ 38,476 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2018-05-10+10,500→ 10,500 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2018-05-10+63,000→ 63,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2018-05-10+10,500→ 27,948 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2018-02-08+2,546→ 17,448 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2017-08-16$22.50/sh−1,378→ 13,622 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2017-05-17+90,000→ 90,000 total
Award
Travere Therapeutics, Inc.$TVTX
Employee Stock Option (right to buy)
2016-08-15+120,000→ 120,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2016-08-15+15,000→ 15,000 total

Companies

Recent Filings

Address

C/O ZEVRA THERAPEUTICS, INC. 1180 CELEBRATION BOULEVARD, SUITE 103

CELEBRATION, FL, 34747

View on SEC.gov